{ "cik": 1213037, "cik_padded": "0001213037", "entityName": "Cardiff Oncology, Inc.", "fiscal_years": [ { "accn": "0001193125-26-067464", "filed": "2026-02-24", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 44000.0, "cash": 17470000.0, "eps_diluted": -0.69, "free_cash_flow": -37967000.0, "net_income": -45851000.0, "operating_cash_flow": -37923000.0, "operating_income": -48960000.0, "revenue": 593000.0, "stockholders_equity": 45388000.0, "total_assets": 61884000.0, "total_liabilities": 16496000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.36344408213624746, "revenue_growth_yoy": -0.13177159590043924, "roa_avg2y": -0.576473842362674, "roa_period_end": -0.7409184926636934, "roe_avg2y": -0.7145406235146529, "roe_period_end": -1.0102009341676215 } }, { "accn": "0001193125-26-067464", "filed": "2026-02-24", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 80000.0, "cash": 51470000.0, "eps_diluted": -0.95, "free_cash_flow": -37773000.0, "net_income": -45431000.0, "operating_cash_flow": -37693000.0, "operating_income": -48651000.0, "revenue": 683000.0, "stockholders_equity": 82949000.0, "total_assets": 97190000.0, "total_liabilities": 14241000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.17168380571194347, "revenue_growth_yoy": 0.39959016393442626, "roa_avg2y": -0.5081000072695957, "roa_period_end": -0.4674452104125939, "roe_avg2y": -0.5950827831918684, "roe_period_end": -0.5476979830980482 } }, { "accn": "0001193125-26-067464", "filed": "2026-02-24", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 582000.0, "cash": 21655000.0, "eps_diluted": -0.93, "free_cash_flow": -31469000.0, "net_income": -41441000.0, "operating_cash_flow": -30887000.0, "operating_income": -45412000.0, "revenue": 488000.0, "stockholders_equity": 69739000.0, "total_assets": 81637000.0, "total_liabilities": 11898000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.17060755101162908, "revenue_growth_yoy": 0.26424870466321243, "roa_avg2y": -0.41895990456356025, "roa_period_end": -0.5076252189570906, "roe_avg2y": -0.4707011506002885, "roe_period_end": -0.5942299143951018 } }, { "accn": "0001628280-24-007948", "filed": "2025-02-27", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1006000.0, "cash": 16347000.0, "eps_diluted": -0.89, "free_cash_flow": -34826000.0, "net_income": -38704000.0, "operating_cash_flow": -33820000.0, "operating_income": -39902000.0, "revenue": 386000.0, "stockholders_equity": 106343000.0, "total_assets": 116191000.0, "total_liabilities": 9848000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.09260600133530181, "revenue_growth_yoy": 0.07520891364902507, "roa_avg2y": -0.2912977214141908, "roa_period_end": -0.3331066950108012, "roe_avg2y": -0.3136975198573513, "roe_period_end": -0.3639543740537694 } }, { "accn": "0001628280-24-007948", "filed": "2024-02-29", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 205000.0, "cash": 11943000.0, "eps_diluted": -0.73, "free_cash_flow": -23245000.0, "net_income": -28291000.0, "operating_cash_flow": -23040000.0, "operating_income": -28855000.0, "revenue": 359000.0, "stockholders_equity": 140417000.0, "total_assets": 149544000.0, "total_liabilities": 9127000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06499925222729441, "revenue_growth_yoy": -0.01912568306010929, "roa_avg2y": -0.19904246300185385, "roa_period_end": -0.18918177927566468, "roe_avg2y": -0.21067485804710043, "roe_period_end": -0.20147845346361193 } }, { "accn": "0001628280-23-006037", "filed": "2023-03-02", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 211000.0, "cash": 130981000.0, "eps_diluted": -1.08, "free_cash_flow": -16526000.0, "net_income": -19307000.0, "operating_cash_flow": -16315000.0, "operating_income": -19086000.0, "revenue": 366000.0, "stockholders_equity": 128158000.0, "total_assets": 134727000.0, "total_liabilities": 6569000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.051257042088671795, "roa_avg2y": -0.2612345150017577, "roa_period_end": -0.1433046085788298, "roe_avg2y": -0.28503727762604264, "roe_period_end": -0.15064997893225548 } }, { "accn": "0001628280-22-003808", "filed": "2022-02-24", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 67622.0, "cash": 10195292.0, "free_cash_flow": -13335122.0, "net_income": -16414159.0, "operating_cash_flow": -13267500.0, "operating_income": -16678494.0, "stockholders_equity": 7312000.0, "total_assets": 13086546.0, "total_liabilities": 5775202.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7898252188183807, "roa_avg2y": -1.204309307715216, "roa_period_end": -1.254277408263418, "roe_avg2y": -1.8870979349963486, "roe_period_end": -2.2448248085339166 } }, { "accn": "0001628280-21-003277", "filed": "2021-02-25", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5100.0, "cash": 11453133.0, "eps_diluted": -8.26, "free_cash_flow": -13204113.0, "net_income": -16461178.0, "operating_cash_flow": -13199013.0, "operating_income": -17053412.0, "stockholders_equity": 10084192.0, "total_assets": 14172496.0, "total_liabilities": 4088304.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.405417112248557, "roa_avg2y": -1.2443516732176287, "roa_period_end": -1.1614875742423918, "roe_avg2y": -1.9844341563705392, "roe_period_end": -1.6323745125043236 } }, { "accn": "0001628280-20-002424", "filed": "2020-02-27", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 101101.0, "cash": 8225764.0, "eps_diluted": -51.76, "net_income": -24906744.0, "operating_income": -25595797.0, "stockholders_equity": 6506107.0, "total_assets": 12284941.0, "total_liabilities": 5778834.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8882168707031717, "roa_avg2y": -0.885803791181035, "roe_avg2y": -1.8959055190394427, "roe_period_end": -3.828210018679373 } }, { "accn": "0001628280-19-002546", "filed": "2019-03-06", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 823483.0, "cash": 13915094.0, "eps_diluted": -1.37, "net_income": -39203719.0, "operating_income": -40145611.0, "stockholders_equity": 19768139.0, "total_assets": 43950411.0, "total_liabilities": 24182272.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.223295323854208, "roa_period_end": -0.8919989166881739, "roe_period_end": -1.9831770203558363 } }, { "accn": "0001628280-17-002601", "filed": "2017-03-15", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -1.21 }, "period_end": "2015-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-067464", "filed": "2026-02-24", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001213037.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001213037.json" }, "ticker": "CRDF" }